In surgery, the success of a procedure can often depend upon the ability to efficiently and effectively control blood loss. Achieving that control--or hemostasis--is a complex biological process with no single solution.
Ethicon’s decades of experience in the OR have led us to develop a portfolio of hemostatic products that allow surgeons to respond to almost any situation--especially the most emergent kind. With the acquisition of Omrix Biopharmaceuticals, world leader in active biologic-based products, we have expanded our capabilities in this area.
Among our current hemostasis portfolio, the SURGICEL® Family of Absorbable Hemostats continue to be the gold standard of bleeding control, available in a variety of absorbable,1,2 easy to administer forms.
For more information, please visit: www.surgicel.com For information on our full line of hemostats, please visit http://www.ethicon360.com/products/ethicon-biosurgery.
1. Data on file, Ethicon, Inc.
2. See Full Prescribing Information